In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SurModics, Inc.

http://www.surmodics.com/

Latest From SurModics, Inc.

SurModics Resumes TRANSCEND Trial Of SurVeil Drug-Coated Balloon

SurModics suspended the trial with their SurVeil drug-coated balloon in March after the US FDA sent a letter to physicians alerting them to possible safety problem with paclitaxel-coated devices. The company has updated the patient consent form and established a new patient follow-up program for the trial.

Clinical Trials Cardiovascular

SurModics Recruits Abbott To Commercialize SurVeil Drug-Coated Balloon

Abbott will pay SurModics $25m upfront and up to $67m in milestones for the exclusive right to commercialization SurVeil worldwide.

Cardiology Cardiovascular

Deals In Depth: January 2016

Nestle Health signed a $1.9 billion microbiome deal with Seres; Thermo Fisher paid $1.3 billion for fellow life sciences company Affymetrix. Biopharma and device financing totaled $2.9 billion and $254 million, respectively.

BioPharmaceutical Medical Device

Market Update: Growth And Opportunities In Peripheral Artery Disease

Drug-coated balloon (DCBs) catheters have become the latest weapon in the fight against peripheral artery disease in the US, although they have been in use in Europe for some time. While the number of procedures employing DCBs is still dwarfed by conventional angioplasty procedures, they are expected to grow at a much faster rate, fueling a market projected to reach $1 billion by 2020; meanwhile other procedures such as mechanical atherectomy are also expected to show significant growth.

Medical Device Innovation
See All

Company Information

  • Industry
  • Distributors
  • Medical Devices
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Other Names / Subsidiaries
    • Brookwood Pharmaceuticals, Inc.
    • BioFX Laboratories, Inc.
    • Creagh Medical Ltd.
    • Embolitech Inc
    • NorMedix, Inc.
UsernamePublicRestriction

Register